Cargando…

Remdesivir is a delayed translocation inhibitor of SARS-CoV-2 replication

Remdesivir is a nucleoside analog approved by the US FDA for treatment of COVID-19. Here, we present a 3.9-Å-resolution cryo-EM reconstruction of a remdesivir-stalled RNA-dependent RNA polymerase complex, revealing full incorporation of 3 copies of remdesivir monophosphate (RMP) and a partially inco...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bravo, Jack P.K., Dangerfield, Tyler L., Taylor, David W., Johnson, Kenneth A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2021
Materias:	Short Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843106/ https://www.ncbi.nlm.nih.gov/pubmed/33631104 http://dx.doi.org/10.1016/j.molcel.2021.01.035

Ejemplares similares

Conformational dynamics during high-fidelity DNA replication and translocation defined using a DNA polymerase with a fluorescent artificial amino acid
por: Dangerfield, Tyler L., et al.
Publicado: (2020)

Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of Remdesivir, a SARS-CoV-2 Replication Inhibitor
por: Humeniuk, Rita, et al.
Publicado: (2021)

Substrate Specificity and Kinetics of RNA Hydrolysis by SARS-CoV-2 NSP10/14 Exonuclease
por: Dangerfield, Tyler L., et al.
Publicado: (2022)

Simeprevir Potently Suppresses SARS-CoV-2 Replication and Synergizes with Remdesivir
por: Lo, Ho Sing, et al.
Publicado: (2021)

Remdesivir–ivermectin combination displays synergistic interaction with improved in vitro activity against SARS-CoV-2
por: Jeffreys, Laura N., et al.
Publicado: (2022)

Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro
por: Choy, Ka-Tim, et al.
Publicado: (2020)

Synergistic Inhibition of SARS-CoV-2 Replication Using Disulfiram/Ebselen and Remdesivir
por: Chen, Ting, et al.
Publicado: (2021)

SARS-CoV-2 viral load dynamics in immunocompromised critically ill patients on remdesivir treatment
por: Lahmer, Tobias, et al.
Publicado: (2022)

Remdesivir Is Effective in Combating COVID-19 because It Is a Better Substrate than ATP for the Viral RNA-Dependent RNA Polymerase
por: Dangerfield, Tyler L., et al.
Publicado: (2020)

Hepatitis C Virus Protease Inhibitors Suppress Virus Replication and Act Synergistically with the SARS-CoV2 Polymerase Inhibitor Remdesivir
por: Bafna, Khushboo, et al.
Publicado: (2021)

Expression and purification of tag-free SARS-CoV-2 RNA-dependent RNA polymerase in Escherichia coli
por: Dangerfield, Tyler L., et al.
Publicado: (2021)

Mechanisms of inhibition of viral RNA replication by nucleotide analogs
por: Johnson, Kenneth A., et al.
Publicado: (2021)

Correction to “Synergistic Inhibition of SARS-CoV-2 Replication Using Disulfiram/Ebselen and Remdesivir”
por: Chen, Ting, et al.
Publicado: (2021)

Rapid detection of SARS-CoV-2, replicating or non-replicating, using RT-PCR
por: Liao, Ming, et al.
Publicado: (2021)

Translocation pause of remdesivir-containing primer/template RNA duplex within SARS-CoV-2’s RNA polymerase complexes
por: Shi, Yuanjun, et al.
Publicado: (2022)

Methotrexate inhibits SARS‐CoV‐2 virus replication “in vitro”
por: Caruso, Arnaldo, et al.
Publicado: (2020)

Persistent replication of SARS-CoV-2 in a severely immunocompromised patient treated with several courses of remdesivir
por: Camprubí, Daniel, et al.
Publicado: (2021)

Therapeutic Efficacy and Outcomes of Remdesivir versus Remdesivir with Tocilizumab in Severe SARS-CoV-2 Infection
por: Vulturar, Damiana-Maria, et al.
Publicado: (2022)

Early experience with remdesivir in SARS-CoV-2 pneumonia
por: Durante-Mangoni, Emanuele, et al.
Publicado: (2020)

Contre Sars-CoV-2, brequinar ou remdesivir ?
por: Manus, Jean-Marie
Publicado: (2021)

Remdesivir therapy associated with Bradycardia in SARS‐CoV2
por: Kumar, Sabina, et al.
Publicado: (2021)

Mechanism of SARS-CoV-2 polymerase stalling by remdesivir
por: Kokic, Goran, et al.
Publicado: (2021)

Enhanced Remdesivir Analogues to Target SARS-CoV-2
por: Majima, Ryuichi, et al.
Publicado: (2023)

Kinetics of DNA strand transfer between polymerase and proofreading exonuclease active sites regulates error correction during high-fidelity replication
por: Dangerfield, Tyler L., et al.
Publicado: (2022)

Probing remdesivir nucleotide analogue insertion to SARS-CoV-2 RNA dependent RNA polymerase in viral replication
por: Romero, Moises E., et al.
Publicado: (2022)

Remdesivir and Ledipasvir among the FDA-Approved Antiviral Drugs Have Potential to Inhibit SARS-CoV-2 Replication
por: Pirzada, Rameez Hassan, et al.
Publicado: (2021)

Anti-SARS-CoV-2 Activity of Extracellular Vesicle Inhibitors: Screening, Validation, and Combination with Remdesivir
por: Kongsomros, Supasek, et al.
Publicado: (2021)

Arguments in favour of remdesivir for treating SARS-CoV-2 infections
por: Ko, Wen-Chien, et al.
Publicado: (2020)

Remdesivir in kidney transplant patients with SARS-CoV-2 pneumonia()
por: Cacho, Judit, et al.
Publicado: (2022)

Combinational benefit of antihistamines and remdesivir for reducing SARS-CoV-2 replication and alleviating inflammation-induced lung injury in mice
por: Wu, Meng-Li, et al.
Publicado: (2022)

D,L-Lysine-Acetylsalicylate + Glycine (LASAG) Reduces SARS-CoV-2 Replication and Shows an Additive Effect with Remdesivir
por: Jungwirth, Johannes, et al.
Publicado: (2022)

Antiviral activity of ciclesonide acetal derivatives blocking SARS-CoV-2 RNA replication
por: Tsuji, Genichiro, et al.
Publicado: (2022)

Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice
por: Pruijssers, Andrea J., et al.
Publicado: (2020)

The folate antagonist methotrexate diminishes replication of the coronavirus SARS-CoV-2 and enhances the antiviral efficacy of remdesivir in cell culture models
por: Stegmann, Kim M., et al.
Publicado: (2021)

Quantifying the effect of remdesivir in rhesus macaques infected with SARS-CoV-2
por: Dobrovolny, Hana M.
Publicado: (2020)

Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2
por: Williamson, Brandi N., et al.
Publicado: (2020)

Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2
por: Williamson, Brandi N., et al.
Publicado: (2020)

Remdesivir, la esperanza antiviral frente al SARS-CoV-2
por: Reina, Jordi
Publicado: (2020)

Viable SARS-CoV-2 shedding under remdesivir and dexamethasone treatment
por: Yoon, Jin Gu, et al.
Publicado: (2022)

The strand-biased transcription of SARS-CoV-2 and unbalanced inhibition by remdesivir
por: Zhao, Yan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dbg5suvg301pghitvc5d9opg4k